Dr. Maria G. Segura is a board-certified Pediatric Infectious Diseases physician with a strong foundation in general pediatrics and a passion for preventive care. Her clinical interests include general pediatrics, pediatric infectious diseases, and the promotion of preventive health through vaccines.
Dr. Segura’s research focuses on Group A Streptococcus and the management of infections in immunocompromised populations, with the goal of improving outcomes for medically vulnerable children. She brings a thoughtful, evidence-based approach to patient care and is committed to advancing pediatric infectious disease research and practice.
General Pediatrics, Pediatric Infectious Diseases, Musculoskeletal Infections, Preventive Care and Vaccines
Group A Streptococcus and the immunocompromised population.
Aboulhosn, A., Sanson, M. A., Vega, L. A., Segura, M. G., Summer, L. M., Joseph, M., McNeil, J. C., & Flores, A. R.: Influence of the COVID-19 Pandemic on Antimicrobial Resistance Patterns in Pediatric Group A Streptococcus Infections in Houston, TX. 13th Annual Pediatric Research Symposium. 05/2024.
Aboulhosn, A., Sanson, M. A., Vega, L. A., Segura, M. G., Summer, L. M., Joseph, M., McNeil, J. C., & Flores, A. R.: Increases in group A streptococcal infections in the pediatric population in Houston, TX, 2022. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 04/2023
Hennessy, M. Wahba, A. Felix, K. Cabrera, M. Segura, M. Kundra, V. Ravoori, M. Stewart, J. Kleinerman, E. Jensen, V. Gopalakrishnan, V. Pena, R. Quach, P. Kim, G. Kivimäe, S. Madakamutil, L. Overwijk, W. Zalevsky, J. Gordon, N.: Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma. International Journal of Cancer. 05/2020.
Licensed by the Texas Medical Board
American Board of Pediatrics